Abstract
Objectives
Renal biopsy has been used extensively in systemic lupus erythematosus (SLE) with renal involvement. However, there is no complete agreement about the need for renal biopsy at presentation. The goal of this study is to define the role of renal biopsy as a therapeutic guide in new-onset SLE with renal involvement.
Methods
We retrospectively analyzed renal biopsy findings in 131 SLE patients who received renal biopsy within 3 months from the diagnosis of SLE.
Results
In patients presenting with acute renal failure, 91% of patients had proliferative lupus nephritis (LN) (class IV, mixed class V + III) and 9% had non-proliferative lupus nephropathy (pure class V). In patients presenting with nephrotic range proteinuria, proliferative LN (class III, IV, mixed class V + III) and non-proliferative lupus nephropathy (class II, pure class V) accounted for 55% and 36% of patients, respectively, whereas 9% had non-lupus nephropathy. With the exception of anti-double-stranded DNA, no clinical findings correlated with pathology. In patients presenting with sub-nephrotic proteinuria, 49% of patients had proliferative LN (class III, IV, mixed class V + III) and 51% had non-proliferative lupus nephropathy (class II, pure class V). Decreased C4 levels were more common in patients with proliferative LN (P = 0.031). In patients presenting with isolated hematuria, all were not active form nephropathy.
Conclusions
Our data suggested that similar clinical features may be observed despite very different classes of LN. Therefore, in new-onset SLE patients with clinical renal disease, early renal biopsy may be helpful in planning the treatment.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cameron JS (2001) Systemic lupus erythematosus. In: Neilson EG, Couser WG (eds) Immunologic renal diseases, 2nd edn. Lippincott-Raven, Philadelphia, pp 1057–1104
Mok CC (2009) Membranous nephropathy in systemic lupus erythematosus: a therapeutic enigma. Nat Rev Nephrol 5:212–220
Austin HA 3rd, Muenz LR, Joyce KM, Antonovych TA, Kullick ME, Klippel JH et al (1983) Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am J Med 75:382–391
Weening JJ, D’Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB et al (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 65:521–530
Ponticelli C, Zucchelli P, Moroni G, Cagnoli L, Banfi G, Pasquali S (1987) Long-term prognosis of diffuse lupus nephritis. Clin Nephrol 28:263–271
Cameron JS (1994) Lupus nephritis in childhood and adolescence. Pediatr Nephrol 8:230–249
Vachvanichsanong P, Dissaneewate P, McNeil E (2009) Diffuse proliferative glomerulonephritis does not determine the worst outcome in childhood-onset lupus nephritis: a 23-year experience in a single centre. Nephrol Dial Transplant 24:2729–2734
Schwartz MM, Lan SP, Bernstein J, Hill GS, Holley K, Lewis EJ (1993) Irreproducibility of the activity and chronicity indices limits their utility in the management of lupus nephritis. Lupus Nephritis Collaborative Study Group. Am J Kidney Dis 21:374–377
Pollak VE, Pirani CL, Schwartz FD (1964) The natural history of the renal manifestations of systemic lupus erythematosus. J Lab Clin Med 63:537–550
Esdaile JM, Mackenzie T, Barré P, Danoff D, Osterland CK, Somerville P et al (1992) Can experienced clinicians predict the outcome of lupus nephritis? Lupus 1:205–214
Salach RH, Cash JM (1996) Managing lupus nephritis: algorithms for conservative use of renal biopsy. Cleve Clin J Med 63:106–115
Jakez-Ocampo J, Arreola-Zavala R, Richaud-Patin Y, Romero-Díaz J, Llorente L (2004) Lupus nephritis outcome with and without renal biopsy: a 5-year comparative study. J Clin Rheumatol 10:289–294
Esdaile JM, Joseph L, MacKenzie T, Kashgarian M, Hayslett JP (1994) The benefit of early treatment with immunosuppressive agents in lupus nephritis. J Rheumatol 21:2046–2051
Leehey DJ, Katz AI, Azaran AH, Aronson AJ, Spargo BH (1982) Silent diffuse lupus nephritis: long-term follow-up. Am J Kidney Dis 2(Suppl.1):188–196
Christopher-Stine L, Siedner M, Lin J, Haas M, Parekh H, Petri M, Fine DM (2007) Renal biopsy in lupus patients with low levels of proteinuria. J Rheumatol 34:332–335
Esdaile JM, Abrahamowicz M, MacKenzie T, Hayslett JP, Kashgarian M (1994) The time-dependence of long-term prediction in lupus nephritis. Arthritis Rheum 37:359–368
Fiehn C, Hajjar Y, Mueller K, Waldherr R, Ho AD, Andrassy K (2003) Improved clinical outcome of lupus nephritis during the past decade: importance of early diagnosis and treatment. Ann Rheum Dis 62:435–439
Faurschou M, Starklint H, Halberg P, Jacobsen S (2006) Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure. J Rheumatol 33:1563–1569
Contreras G, Roth D, Pardo V, Striker LG, Schultz DR (2002) Lupus nephritis: a clinical review for practicing nephrologists. Clin Nephrol 57:95–107
Ponticelli C, Glassock RJ, Moroni G (2010) Induction and maintenance therapy in proliferative lupus nephritis. J Nephrol 23:9–16
Cameron JS (1999) Lupus nephritis: an historical perspective 1968–1998. J Nephrol 12(Suppl. 2):29–41
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wen, YK. Renal biopsy findings in new-onset systemic lupus erythematosus with clinical renal disease. Int Urol Nephrol 43, 801–806 (2011). https://doi.org/10.1007/s11255-011-9911-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-011-9911-3